information

Whoever comes in this website may find a hint

Phage therapy is influenced by:

Phage therapy is influenced by:

Country :
the epidemiological situation is different from country to country in terms of circulating bacteria and bacteriophages. Example: a lytic phages from Italy may be no active on the same bacteria (genus and species) isolated from another country and vice versa.
Chronolability
Mutation rate
Phenotypical delay
Phage cocktail
My point of view

From Wikipedia


If the target host* of a phage therapy treatment is not
an animal the term "
biocontrol" (as in phage-mediated biocontrol of bacteria) is usually employed, rather than "phage therapy".

"In silico"

From:"Genomics,Proteomics and Clinical Bacteriology", N.Woodford and Alan P.Johnson

Phrase that emphasizes the fact that many molecular biologists spend increasing amounts of their time in front of a computer screen, generating hypotheses that can subsequently be tested and (hopefully) confirmed in the laboratory.

Saturday, 5 July 2014

Commercial phage preparations ( first part)

 

Old post

Saturday, 19 June 2010





From Eliava Institute documents:







Documents : year 1984 and year 2005
(or 07? )



Phage preparations















Staphylococcus aureus phage Sb-1 

Revue




The phage Sb-1
  is used for intravenous bacteriophage preparation.

 






Pseudomonas aeuriginosa phages




Phage Cocktail






Phage parameters




Table





 
 

Microgen

(Russian company)